Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal (Q37163861)

18 August 2017

1 reference

title

Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal (English)

1 reference

18 August 2017

0 references

Mariella De Biasi

1

1 reference

18 August 2017

Ramiro Salas

series ordinal

2

1 reference

18 August 2017

publication date

14 May 2008

1 reference

Experimental Biology and Medicine

18 August 2017

published in

1 reference

18 August 2017

volume

233

1 reference

18 August 2017

issue

8

1 reference

18 August 2017

page(s)

917-929

1 reference

18 August 2017

cites work

The many faces of CREB

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Exposure to nicotine and sensitization of nicotine-induced behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Shape of the relapse curve and long-term abstinence among untreated smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Smoking withdrawal dynamics: III. Correlates of withdrawal heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotinic acetylcholine receptors and the regulation of neuronal signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Desensitization of nicotinic ACh receptors: shaping cholinergic signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Desensitization of neuronal nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Molecular and cellular aspects of nicotine abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotine activation of alpha4* receptors: sufficient for reward, tolerance, and sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Genetic dissociation of two behaviors associated with nicotine addiction: beta-2 containing nicotinic receptors are involved in nicotine reinforcement but not in withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Decreased signs of nicotine withdrawal in mice null for the beta4 nicotinic acetylcholine receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Decreased withdrawal symptoms but normal tolerance to nicotine in mice null for the alpha7 nicotinic acetylcholine receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Effects of abstinence from tobacco: valid symptoms and time course

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Signs and symptoms of tobacco withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Psychophysiological effects of nicotine abstinence and behavioral challenges in habitual smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Self-reported abstinence effects in the first month after smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Perceived stress, quitting smoking, and smoking relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Neuroregulators and the reinforcement of smoking: towards a biobehavioral explanation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Symptoms of tobacco withdrawal. A replication and extension.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Characterization of tobacco withdrawal symptoms: transdermal nicotine reduces hunger and weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Urges to smoke during the first month of abstinence: relationship to relapse and predictors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Who gets what symptom? Effects of psychiatric cofactors and nicotine dependence on patterns of smoking withdrawal symptomatology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Smoking cessation in the workplace: evaluation of relapse factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of interrelationships

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Tobacco abstinence, smoking cues, and the reinforcing value of smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Increased desire to smoke during acute stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

How does stress increase risk of drug abuse and relapse?

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Sex differences in depression: a role for preexisting anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Metabotropic glutamate receptor antagonists: novel therapeutics for nicotine dependence and depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotine dependence, depression, and gender: characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Understanding comorbidity between PTSD and substance use disorders: two preliminary investigations.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Characterization of spontaneous and precipitated nicotine withdrawal in the mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotine abstinence in the mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Animal models and treatments for addiction and depression co-morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Neurobiology of the nicotine withdrawal syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Dramatic decreases in brain reward function during nicotine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Tolerance to nicotine's effects in the elevated plus-maze and increased anxiety during withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Withdrawal from chronic nicotine administration impairs contextual fear conditioning in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Beta2 subunit containing acetylcholine receptors mediate nicotine withdrawal deficits in the acquisition of contextual fear conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotine replacement therapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Mecamylamine increases nicotine preference and attenuates nicotine discrimination

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Cytisine for smoking cessation: a literature review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

In pursuit of alpha4beta2 nicotinic receptor partial agonists for smoking cessation: carbon analogs of (-)-cytisine

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Non-nicotinic therapies for smoking cessation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Characterization of the effects of bupropion on the reinforcing properties of nicotine and food in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Modulation of nicotine self-administration in rats by combination therapy with agents blocking alpha 3 beta 4 nicotinic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Effect of bupropion on nicotine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Bupropion attenuates nicotine abstinence syndrome in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Non-nicotine pharmacotherapy for smoking cessation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Lasting reduction in mesolimbic dopamine neuronal activity after morphine withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Increase of extracellular dopamine in the medial prefrontal cortex during spontaneous and naloxone-precipitated opiate abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Involvement of the endocannabinoid system in drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Rimonabant for overweight or obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Short-term weight gain in abstaining women smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Drug addiction, dysregulation of reward, and allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Brain substrates for increased drug seeking during protracted withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Augmented accumbal serotonin levels decrease the preference for a morphine associated environment during withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The neurobiology of drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Prolonged activation of mesolimbic dopaminergic neurons by morphine withdrawal following clonidine: participation of imidazoline and norepinephrine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Effects of nicotine and mecamylamine-induced withdrawal on extracellular dopamine and acetylcholine in the rat nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Neuroscience of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Selective activation of mesocortical DA system by stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Single-neuron responses to emotional visual stimuli recorded in human ventral prefrontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The anxiogenic beta-carboline FG 7142 selectively increases dopamine release in rat prefrontal cortex as measured by microdialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Prefrontal dopamine is directly involved in the anxiogenic interoceptive cue of pentylenetetrazol but not in the interoceptive cue of chlordiazepoxide in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Reboxetine: attenuation of intravenous nicotine self-administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Bupropion for smoking cessation: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Effects of chronic oral nicotine treatment and its withdrawal on locomotor activity and brain monoamines in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Alpha bungarotoxin-1.4 nm gold: a novel conjugate for visualising the precise subcellular distribution of alpha 7* nicotinic acetylcholine receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Control of the release of newly synthetized 3H-5-hydroxytryptamine by nicotinic and muscarinic receptors in rat hypothalamic slices

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Effects of systemic nicotine on serotonin release in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Tobacco withdrawal in self-quitters

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Cigarette smoking: implications for psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Effects of nicotine administration and its withdrawal on plasma corticosterone and brain 5-hydroxyindoles

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The effects of nicotine administration on 5-HT uptake and biosynthesis in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The dorsal raphé nucleus is a crucial structure mediating nicotine's anxiolytic effects and the development of tolerance and withdrawal responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Sites of action of ondansetron to inhibit withdrawal from drugs of abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotine-induced antinociception, rewarding effects, and physical dependence are decreased in mice lacking the preproenkephalin gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

18-MC acts in the medial habenula and interpeduncular nucleus to attenuate dopamine sensitization to morphine in the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Long-term potentiation of excitatory inputs to brain reward areas by nicotine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The ups and downs of addiction: role of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The mGluR5 antagonist MPEP decreased nicotine self-administration in rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Group II metabotropic and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate glutamate receptors regulate the deficit in brain reward function associated with nicotine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Transient behavioral sensitization to nicotine becomes long-lasting with monoamine oxidases inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Monoamine oxidase inhibition dramatically increases the motivation to self-administer nicotine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The neural basis of addiction: a pathology of motivation and choice

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Multiple Dopamine Functions at Different Time Courses

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

NEURAL MECHANISMS OF ADDICTION: The Role of Reward-Related Learning and Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Stress, dysregulation of drug reward pathways, and the transition to drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

A computational substrate for incentive salience

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

A neural substrate of prediction and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Lateral habenula as a source of negative reward signals in dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Evidence for, and nature of, the tonic inhibitory influence of habenulointerpeduncular pathways upon cerebral dopaminergic transmission in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The ibogaine medical subculture

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Mechanisms of Antiaddictive Actions of Ibogainea.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Anti-addictive actions of an iboga alkaloid congener: a novel mechanism for a novel treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Demonstration of synaptic input from prefrontal cortex to the habenula i the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The thalamus and neuropsychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The dorsal diencephalic conduction system: a review of the anatomy and functions of the habenular complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Efferent connections of the habenular nuclei in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Afferent connections of the habenular nuclei in the rat. A horseradish peroxidase study, with a note on the fiber-of-passage problem

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Cytoarchitecture, fiber connections, and some histochemical aspects of the interpeduncular nucleus in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Serotonergic and nonserotonergic projections from the rat interpeduncular nucleus to the septum, hippocampal formation and raphe: a combined immunocytochemical and fluorescent retrograde labelling study of neurons in the apical subnucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The nicotinic acetylcholine receptor subunit alpha 5 mediates short-term effects of nicotine in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

The alpha3 and beta4 nicotinic acetylcholine receptor subunits are necessary for nicotine-induced seizures and hypolocomotion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotinic acetylcholine receptor subunit mRNA expression and channel function in medial habenula neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Neuronal and astrocyte expression of nicotinic receptor subunit beta4 in the adult mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Acetylcholine release in interpeduncular nucleus following the stimulation of habenula

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Distribution of alpha 2, alpha 3, alpha 4, and beta 2 neuronal nicotinic receptor subunit mRNAs in the central nervous system: a hybridization histochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Comparison of alpha2 nicotinic acetylcholine receptor subunit mRNA expression in the central nervous system of rats and mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Nicotine gates long-term potentiation in the hippocampal CA1 region via the activation of alpha2* nicotinic ACh receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Autonomic function in mice lacking alpha5 neuronal nicotinic acetylcholine receptor subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Increased sensitivity to nicotine-induced seizures in mice expressing the L250T alpha 7 nicotinic acetylcholine receptor mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Absence of alpha7-containing neuronal nicotinic acetylcholine receptors does not prevent nicotine-induced seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Decreased anxiety-like behavior in beta3 nicotinic receptor subunit knockout mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

Response to stress of mesocortico-frontal dopaminergic neurones in rats after long-term isolation

21 January 2018

1 reference

https://api.crossref.org/works/10.3181%2F0712-MR-355

21 January 2018

Identifiers

DOI

10.3181/0712-MR-355

1 reference

18 August 2017

1 reference